Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split
Jaguar Health received an extension from the Nasdaq Hearings Panel until May 15, 2026, to regain compliance with the $1.00 minimum bid price requirement. To ensure the stock meets this threshold, the company will effect a 1-for-35 reverse stock split effective April 30, 2026, with shares trading on a split-adjusted basis at the market open.
Key figures
- Split ratio
- 1-for-35
- Effective date
- April 30, 2026
- Extension date
- May 15, 2026
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.